A Retrospective Study to Assess Patient-Reported Treatment Experience With Over-the-Counter Analgesic Products
NCT07931859, Not yet recruiting, HALEON
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | A Retrospective Study to Assess Patient-Reported Treatment Experience With Over-the-Counter Analgesic Products | ClinicalTrials.gov |
| NCT number | NCT07931859 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Enrollment | 600 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | HALEON | ClinicalTrials.gov |
| Conditions | Pain | ClinicalTrials.gov |
| Interventions | Paracetamol | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Perceived Onset of Relief After Product Use | Within the past 1 month from time of participation | Thinking about the recent pain episode, participants will report approximate time for their pain to decrease after using the product. | ClinicalTrials.gov |
| Primary | Perceived Relief From Product Use | Within the past 1 month from time of participation | Thinking about the recent pain episode, participants will describe the first sign of symptom relief they perceived after using the product. | ClinicalTrials.gov |
| Secondary | Characterization of the Pain Profile | Within the past 1 month from time of participation | The information on pain such as type, frequency, severity, and duration will be collected from the participants. | ClinicalTrials.gov |
| Secondary | Quality of Life (QoL) Assessment Before and After Using the Product Post for Occasional Pain | Within the past 1 month from time of participation | Thinking about most recent pain episode, participants will be asked to respond to QoL questions related to effect of pain on the aspects of their daily life before and after using the product. The responses will be scored using a 5-point scale, where 1= Not at all, and 5= Significantly. Lower score indicates better quality of life. | ClinicalTrials.gov |
| Secondary | Sources of Product Information and Trust in Product | Within the past 1 month from time of participation | The information around sources of product information and how much does participants trust the product for mild to moderate or occasional pain relief will be collected. | ClinicalTrials.gov |
| Secondary | Product Switch Behaviors | Within the past 1 month from time of participation | The information around the reasons for switching from the other brands will be collected. | ClinicalTrials.gov |
| Secondary | Perceived Difference in Speed of Analgesia Onset | Within the past 1 month from time of participation | Participants will respond to a question- Compared with other brand(s) used in the past, how quickly does this product begin to relieve headache/ muscle ache. Response will be scored on scale 1= much faster to 5= much slower. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)